Pharmaceutical

Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion

Rona Therapeutics has secured $35m in its Series A+ financing round to advance its metabolic siRNA pipeline in clinical settings.

Jul 20, 2024 - 04:00
Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion
Rona Therapeutics has secured $35m in its Series A+ financing round to advance its metabolic siRNA pipeline in clinical settings.
Read the original article

Tags:

Previous Article

Seventh patient ‘cured’ of HIV among highlights at AIDS 2024

Next Article

Meitheal gains rights to CONTEPO from Nabriva in North America

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Avistone raises $140m to support drug research and development

Avistone raises $140m to support drug research and deve...

Jan 5, 2024

STAT+: Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access

STAT+: Solicitor general urges Supreme Court to review ...

Mar 30, 2023

STAT+: Pharmalittle: Exec nominated to Biogen board is mother of outgoing director’s child; telehealth company pauses Wegovy ads amid shortages

STAT+: Pharmalittle: Exec nominated to Biogen board is ...

Jun 14, 2023